Photo of Christopher S. Lathan,   MD, MS, MPH

Christopher S. Lathan, MD, MS, MPH

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-6041
Fax: (617) 632-4088

Christopher S. Lathan, MD, MS, MPH

Dana-Farber Cancer Institute


  • Assistant Professor, Medicine, Harvard Medical School



  • Physician Liason, Initiative to Eliminate Cancer Disparities

Research Abstract

My primary research interests and clinical work focuses on care provided to lung cancer patients, particularly patients who are members of ethnic and racial minority groups. I am interested in all areas of care delivery and feel that community engagement and assessment is of utmost importance. Cancer patients are vulnerable and knowledge about the distribution of symptoms both physical and psychological is invaluable in the assessment of disparities.

My current research interests focus on racial disparities in lung cancer, and on improving access to care for underserved cancer patients. Currently I am involved with the Lung Cancer Disparities Center run by Dr. David Williams at the Harvard School of Public Health as an co- investigator on multiple projects including (1) sequencing somatic mutations in African-Americans with lung cancer. (2) Examining socioeconomic changes in the NCI CanCORS data set. (3) Examining the relative effects of socioeconomic status on survival in lung cancer. In addition am currently running an outreach oncology clinic as in a Federally Qualified health center in Roxbury, MA. This program is an innovative project with the aim of reducing disparities in cancer mortality locally.


Powered by Harvard Catalyst
  • Sholl LM, Nishino M, Pokharel S, Mino-Kenudson M, French CA, Janne PA, Lathan C. Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations. J Thorac Oncol 2015; 10:951-9. PubMed
  • Lathan CS, Waldman LT, Browning E, Gagne J, Emmons K. Perspectives of African Americans on Lung Cancer: A Qualitative Analysis. Oncologist 2015. PubMed
  • Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract 2015; 11:145-50. PubMed
  • Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, Harlan LC. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance. J Clin Oncol 2015; 33:312-8. PubMed
  • John DA, Kawachi I, Lathan CS, Ayanian JZ. Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer 2014; 120:3178-91. PubMed
  • Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D'Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Income inequality and treatment of African American men with high-risk prostate cancer. Urol Oncol 2014. PubMed
  • Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL. Racial disparities in an aging population: The relationship between age and race in the management of African American men with high-risk prostate cancer. 2014. PubMed
  • Traeger L, Cannon S, Keating NL, Pirl WF, Lathan C, Martin MY, He Y, Park ER. Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer. J Clin Oncol 2014; 32:107-13. PubMed
  • Yasuda H, Park E, Yun CH, Sng NJ, Lucena-Araujo AR, Yeo WL, Huberman MS, Cohen DW, Nakayama S, Ishioka K, Yamaguchi N, Hanna M, Oxnard GR, Lathan CS, Moran T, Sequist LV, Chaft JE, Riely GJ, Arcila ME, Soo RA, Meyerson M, Eck MJ, Kobayashi SS, Costa DB. Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med 2013; 5:216ra177. PubMed
  • Waldman LT, Bean W, Levine AL, Cohen-Bearak A, Phelps FA, Svoboda L, Freedman R, Elfiky A, Berlin S, Abel GA, Deutsch C, Lathan CS. Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery. Healthcare (Amst) 2014; 1:130-135. PubMed
  • Lathan C, Frank DA. ACP Journal Club. Review: low-dose CT screening reduces lung cancer and mortality in current or former smokers. Ann Intern Med 2013; 159:JC3. PubMed
  • Jimenez R, Zhang B, Joffe S, Nilsson M, Rivera L, Mutchler J, Lathan C, Paulk ME, Prigerson HG. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment? J Palliat Med 2013; 16:256-62. PubMed
  • Lynch JA, Khoury MJ, Borzecki A, Cromwell J, Hayman LL, Ponte PR, Miller GA, Lathan CS. Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genet Med 2013. PubMed
  • Gray SW, Hicks-Courant K, Lathan CS, Garraway L, Park ER, Weeks JC. Attitudes of patients with cancer about personalized medicine and somatic genetic testing. J Oncol Pract 2013; 8:329-35, 2 p following 335. PubMed
  • Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA. Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma. Clin Cancer Res 2012; 18:5773-5779. PubMed
  • Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol 2012; 36:1222-7. PubMed
  • Lathan CS, Okechukwu C, Drake BF, Bennett GG. Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey. Cancer 2010; 116:1981-6. PubMed
  • Schapira L,Gordon-Rowe L,Martignetti R,Washington D,Bartholomay M,Greenberg D,Lathan C,LaFrancesca J,Lynch T,Chabner B. Racism in the chemotherapy infusion unit: a nurse's story. Oncologist 2008; 13:1177-80. PubMed
  • Lathan CS,Neville BA,Earle CC. Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol 2008; 26:4347-52. PubMed
  • Drake BF,Lathan CS,Okechukwu CA,Bennett GG. Racial differences in prostate cancer screening by family history. Ann Epidemiol 2008; 18:579-83. PubMed
  • Balboni TA, Vanderwerker LC, Block SD, Paulk ME, Lathan CS, Peteet JR, Prigerson HG. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol 2007; 25:555-60. PubMed